The arteriovenous malformations (AVM) treatment market involves the diagnosis and management of abnormal connections between arteries and veins in the body, known as arteriovenous malformations. AVMs develop due to abnormal connections between arteries and veins, bypassing the normal capillary bed. These malformations can develop in any part of the body but are commonly seen in the brain and spinal cord. Treatment methods for AVMs include observation, endovascular embolization, surgical resection, stereotactic radiosurgery, and combination therapies.
The arteriovenous malformations market is estimated to be valued at USD 3.14 Bn in 2024 and is expected to reach USD 4.99 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031.
Key players operating in the Arteriovenous Malformations Treatment market are Medtronic, St. Jude Medical, Boston Scientific Corporation, Stryker Corporation, and Terumo Corporation.
The rising prevalence of brain Arteriovenous Malformations Market are driving the demand for effective diagnostic and treatment methods. According to estimates, brain AVMs affect around 1 in 5000 individuals globally.
Technological advancements are expanding treatment options for AVMs. Advanced embolization techniques and devices such as liquid embolic agents and flow-diverting stents have augmented endovascular approaches. The development of gamma knives and linear accelerators have improved the precision and safety of radiosurgery procedures.
Market Trends
Increased focus on early diagnosis - Early detection of AVMs before onset of symptoms or rupture is crucial for improving outcomes. Research efforts aim to discover diagnostic biomarkers and imaging techniques for screening populations at risk.
Combination therapies gaining popularity - Combining endovascular procedures, microsurgery and stereotactic radiotherapy based on AVM location and angioarchitecture has significantly increased obliteration rates compared to single therapies.
Market Opportunities
Growing health insurance coverage in developing regions will boost treatment uptake for AVMs. Developing nations in Asia Pacific and Latin America currently account for over 60% of untreated brain AVM patients.
Technological advancements such as robotic navigation systems, advanced embolic agents and flow diverters are expanding minimally invasive options. This is expected to positively impact the market.
Impact of COVID-19 on Arteriovenous Malformations Market Growth
The COVID-19 pandemic has significantly impacted the growth of the arteriovenous malformations market. During the initial months of the pandemic, many elective surgeries and non-emergency medical procedures were postponed to reduce the burden on healthcare systems and allow hospitals to focus on treating COVID-19 patients. This led to a decline in the number of surgical procedures performed for arteriovenous malformations. Social distancing norms and risk of virus exposure in hospitals also discouraged many patients from seeking immediate treatment.
However, as the pandemic is now under control in many countries due to rapid vaccination drives, the market is recovering steadily. While some delays and backlogs continue, hospitals have streamlined their operations to ensure safety protocols and accommodate non-COVID patients. With more experience in handling coronavirus infected individuals, healthcare facilities are better equipped to treat emergencies and time-critical cases of arteriovenous malformations as well.
Going forward, market players need to focus on strengthening supply chains to avoid disruptions. Investing in digital health solutions can help sustain service delivery. Factors like increased research funding, new product launches and more coverage options by insurers for delayed procedures will support market growth in the post-pandemic times. Coordination between private and public sectors can further aid in effectively managing this patient segment.
Geographical Regions with Concentrated Market Value
The value of the arteriovenous malformations market remains highly concentrated in developed regions like North America and Europe. The availability of advanced diagnostic technologies, skilled professionals, sophisticated treatment centers and favorable reimbursement policies have historically contributed to larger market sizes in countries like the United States, Germany, United Kingdom and France. These regions also see a high prevalence rate of arteriovenous malformations and greater public awareness about its symptoms and management options.
Fastest Growing Regional Market
The Asia Pacific region is poised to witness the fastest growth in the arteriovenous malformations market over the coming years. This is attributed to improving healthcare infrastructures, rising medical expenditures, increasing incidence of neurological disorders and the growing geriatric population in many Asian countries that are more prone to such conditions. Rapid economic expansion has also enhanced the affordability and adoption of premium neurovascular treatment technologies across Asia Pacific nations.
Get more insights on: Arteriovenous Malformations Market
Get this Report in Japanese Language: 動静脈奇形市場
Get this Report in Korean Language: 동정맥 기형 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)